| Dr Ryan Nelson, DO | |
|
1 Genesys Pkwy, Grand Blanc, MI 48439-8065 | |
| (810) 606-5000 | |
| Not Available |
| Full Name | Dr Ryan Nelson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 13 Years |
| Location | 1 Genesys Pkwy, Grand Blanc, Michigan |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093009979 | NPI | - | NPPES |
| 5101019410 | Other | MI | STATE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 5101019410 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Absolute Home Health Care | Grand blanc, MI | Home health agency |
| Genesys Regional Medical Center - Health Park | Grand blanc, MI | Hospital |
| Ascension St John Hospital | Detroit, MI | Hospital |
| Henry Ford Macomb Hospital | Clinton township, MI | Hospital |
| Park Ridge Health | Hendersonville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greater Flint Sports Medicine Center Pc | 2264332097 | 6 |
| Ortho Xpress Pllc | 9739577966 | 6 |
News Archive
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria.
Emory University School of Medicine researchers have developed tools that enable them to detect small proteins called granulins for the first time inside cells.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
Agilent Technologies Inc. today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures. Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. Last year's fourth-quarter GAAP net income was $25 million, or $0.07 per share.
A team of researchers led by Dmitry Temiakov, PhD, of the Rowan University School of Osteopathic Medicine (RowanSOM), has discovered a molecular 'switch' that controls replication and transcription of mitochondria DNA, a key finding that could influence the development of targeted therapies for cancer, developmental processes related to fertility and aging.
› Verified 7 days ago
| Entity Name | Greater Flint Sports Medicine Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265459150 PECOS PAC ID: 2264332097 Enrollment ID: O20040109000416 |
News Archive
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria.
Emory University School of Medicine researchers have developed tools that enable them to detect small proteins called granulins for the first time inside cells.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
Agilent Technologies Inc. today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures. Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. Last year's fourth-quarter GAAP net income was $25 million, or $0.07 per share.
A team of researchers led by Dmitry Temiakov, PhD, of the Rowan University School of Osteopathic Medicine (RowanSOM), has discovered a molecular 'switch' that controls replication and transcription of mitochondria DNA, a key finding that could influence the development of targeted therapies for cancer, developmental processes related to fertility and aging.
› Verified 7 days ago
| Entity Name | Ella E M Brown Charitable Circle |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366591794 PECOS PAC ID: 1254228745 Enrollment ID: O20040616001008 |
News Archive
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria.
Emory University School of Medicine researchers have developed tools that enable them to detect small proteins called granulins for the first time inside cells.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
Agilent Technologies Inc. today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures. Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. Last year's fourth-quarter GAAP net income was $25 million, or $0.07 per share.
A team of researchers led by Dmitry Temiakov, PhD, of the Rowan University School of Osteopathic Medicine (RowanSOM), has discovered a molecular 'switch' that controls replication and transcription of mitochondria DNA, a key finding that could influence the development of targeted therapies for cancer, developmental processes related to fertility and aging.
› Verified 7 days ago
| Entity Name | Ortho Xpress Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396334983 PECOS PAC ID: 9739577966 Enrollment ID: O20211020003040 |
News Archive
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria.
Emory University School of Medicine researchers have developed tools that enable them to detect small proteins called granulins for the first time inside cells.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
Agilent Technologies Inc. today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures. Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. Last year's fourth-quarter GAAP net income was $25 million, or $0.07 per share.
A team of researchers led by Dmitry Temiakov, PhD, of the Rowan University School of Osteopathic Medicine (RowanSOM), has discovered a molecular 'switch' that controls replication and transcription of mitochondria DNA, a key finding that could influence the development of targeted therapies for cancer, developmental processes related to fertility and aging.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Nelson, DO 861 Health Park Blvd, Grand Blanc, MI 48439-7383 Ph: (810) 210-3577 | Dr Ryan Nelson, DO 1 Genesys Pkwy, Grand Blanc, MI 48439-8065 Ph: (810) 606-5000 |
News Archive
Patients suffering from hospital-acquired pneumonia caused by a type of bacteria that is highly resistant to virtually all antibiotics are twice as likely to die as patients infected with other, less resistant bacteria.
Emory University School of Medicine researchers have developed tools that enable them to detect small proteins called granulins for the first time inside cells.
Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer presented on the press program of the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.
Agilent Technologies Inc. today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures. Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. Last year's fourth-quarter GAAP net income was $25 million, or $0.07 per share.
A team of researchers led by Dmitry Temiakov, PhD, of the Rowan University School of Osteopathic Medicine (RowanSOM), has discovered a molecular 'switch' that controls replication and transcription of mitochondria DNA, a key finding that could influence the development of targeted therapies for cancer, developmental processes related to fertility and aging.
› Verified 7 days ago
Jordan Spencer Mccoy, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-7392 | |
Mark Edward Dyball, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 861 Health Park Blvd, Grand Blanc, MI 48439 Phone: 810-953-0500 Fax: 810-953-0031 | |
Curtis J Barnes, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-7392 | |
Matthew J. Marquart, DO Orthopedic Surgery Medicare: May Accept Medicare Assignments Practice Location: 861 Health Park Blvd, Grand Blanc, MI 48439 Phone: 810-953-0500 | |
Nicholas Bradley Pearson, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5980 | |
Emily J Davidow, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 |